Marker Therapeutics

MRKRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$14.947 M

$0.90 -11.24%

Close of 6 Nov 2026

As of 6 Nov 2026, Marker Therapeutics (MRKR) has a market capitalization of $14.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$12.2M

Loss-making

Shares outstanding

16,673,127

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#396Allarity TherapeuticsALLR$15.3M
#397Neuphoria TherapeuticsNEUP$15.1M
#398Marker TherapeuticsMRKR$14.9M
#399Kyntra BioKYNB$14.8M
#400Optimi HealthOPTH$13.5M

What if Marker Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,693,556

Per share 1,889,075× higher

Bitcoin $1.53T

$91,635.37

Per share 102,215× higher

Apple $5.02T

$300,830.36

Per share 335,561× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for Marker Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.